Morgan Stanley’s Trulieve Cannabis Corp TRLV Stock Holding History

Morgan Stanley’s Portfolio TRLV Stock Details TRLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	+29,697	New	+$286K	﹤0.01%	5790

Other funds holding TRLV

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Morgan Stanley's TRLV Position: Q2 2026 in Review

Morgan Stanley opened a new position in Trulieve Cannabis Corp (TRLV) in Q2 2026: 29,697 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #5790 among its holdings.

125 funds tracked by Wall St. Rank hold TRLV as of Q2 2026.

Morgan Stanley held 29,697 shares of Trulieve Cannabis Corp worth $292K as of Q2 2026.
Trulieve Cannabis Corp was a new Morgan Stanley position in Q2 2026.
Trulieve Cannabis Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5790 holding.
125 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.